Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
Background The coronavirus disease 2019 (COVID‐19) pandemic has resulted in
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
The latest pandemic, coronavirus disease-2019 (COVID-19), is associated with high
prevalence and easy transmission, which is expanding globally with no conventional …
prevalence and easy transmission, which is expanding globally with no conventional …
COVID-19 and the clinical course of rheumatic manifestations
The manifestations of COVID-19 have been evolving over time. Various post-COVID-19
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …
Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
F Vahedifard, K Chakravarthy - Emergent materials, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the recent
outbreak of coronavirus 2019 (COVID-19). Although nearly two decades have passed since …
outbreak of coronavirus 2019 (COVID-19). Although nearly two decades have passed since …
A narrative review of COVID-19 vaccines
B Eroglu, RF Nuwarda, I Ramzan, V Kayser - Vaccines, 2021 - mdpi.com
The COVID-19 pandemic has shaken the world since early 2020 and its health, social,
economic, and societal negative impacts at the global scale have been catastrophic. Since …
economic, and societal negative impacts at the global scale have been catastrophic. Since …
Neutrophils and COVID-19: active participants and rational therapeutic targets
J Hazeldine, JM Lord - Frontiers in immunology, 2021 - frontiersin.org
Whilst the majority of individuals infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, experience mild to …
coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, experience mild to …
Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics
SH Rezkalla, RA Kloner - Trends in cardiovascular medicine, 2021 - Elsevier
Myocarditis is common during viral infection with cases described as early as the influenza
pandemic of 1917, and the current COVID-19 pandemic is no exception. The hallmark is …
pandemic of 1917, and the current COVID-19 pandemic is no exception. The hallmark is …
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
Abstract In December 2019, Coronavirus Disease 2019 (COVID-19) was reported in Wuhan,
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …
Precision therapeutic targets for COVID-19
ZA Krumm, GM Lloyd, CP Francis, LH Nasif… - Virology journal, 2021 - Springer
Beginning in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS …
emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS …
COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
WS Ho, R Zhang, YL Tan, CLL Chai - Pharmacological Research, 2022 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic had grounded the world to a
standstill. As the disease continues to rage two years on, it is apparent that effective …
standstill. As the disease continues to rage two years on, it is apparent that effective …